Pseudomonas aeruginosa exotoxin pyocyanin causes cystic fibrosis airway pathogenesis.
暂无分享,去创建一个
D. Hassett | C. Caldwell | L. Thomashow | Yi Chen | H. Goetzmann | Y. Hao | M. Borchers | L. Young | Dmitri Mavrodi | G. Lau | G. W. Lau
[1] M. Kolb,et al. Role of STAT6 and SMAD2 in a model of chronic allergen exposure: a mouse strain comparison study , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[2] Kyubo Kim,et al. Mucus hypersecretion in asthma: causes and effects , 2009, Current opinion in pulmonary medicine.
[3] Mark A. Miller,et al. Identification of Francisella tularensis Lipoproteins That Stimulate the Toll-like Receptor (TLR) 2/TLR1 Heterodimer* , 2008, Journal of Biological Chemistry.
[4] B. Ma,et al. Inhibition of NF-κB Activation Reduces the Tissue Effects of Transgenic IL-131 , 2007, The Journal of Immunology.
[5] B. Ma,et al. Inhibition of NF-kappaB activation reduces the tissue effects of transgenic IL-13. , 2007, Journal of immunology.
[6] J. Voynow,et al. Respiratory tract mucin genes and mucin glycoproteins in health and disease. , 2006, Physiological reviews.
[7] S. Phan,et al. Molecular mechanisms of and possible treatment strategies for idiopathic pulmonary fibrosis. , 2005, Current pharmaceutical design.
[8] D. Look,et al. Pyocyanin and Its Precursor Phenazine-1-Carboxylic Acid Increase IL-8 and Intercellular Adhesion Molecule-1 Expression in Human Airway Epithelial Cells by Oxidant-Dependent Mechanisms1 , 2005, The Journal of Immunology.
[9] D. Hassett,et al. Modulation of lung epithelial functions by Pseudomonas aeruginosa. , 2005, Trends in microbiology.
[10] D. Nivens,et al. Calcium-Induced Virulence Factors Associated with the Extracellular Matrix of Mucoid Pseudomonas aeruginosa Biofilms , 2005, Journal of bacteriology.
[11] F. Finkelman,et al. Suppressive Effect of IL-4 on IL-13-Induced Genes in Mouse Lung1 , 2005, The Journal of Immunology.
[12] Daniel G. Lee,et al. Pyocyanin Production by Pseudomonas aeruginosa Induces Neutrophil Apoptosis and Impairs Neutrophil-Mediated Host Defenses In Vivo1 , 2005, The Journal of Immunology.
[13] S. Phan,et al. Animal models of pulmonary fibrosis. , 2005, Methods in molecular medicine.
[14] R. Strieter,et al. Mechanisms and mediators of pulmonary fibrosis. , 2005, Critical reviews in immunology.
[15] D. Hassett,et al. The role of pyocyanin in Pseudomonas aeruginosa infection. , 2004, Trends in molecular medicine.
[16] K. Kuwano,et al. The perforin mediated apoptotic pathway in lung injury and fibrosis , 2004, Journal of Clinical Pathology.
[17] M. Burdick,et al. The Role of the Th2 CC Chemokine Ligand CCL17 in Pulmonary Fibrosis1 , 2004, The Journal of Immunology.
[18] R. Homer,et al. Regulation of pulmonary fibrosis by chemokine receptor CXCR3. , 2004, The Journal of clinical investigation.
[19] D. Hassett,et al. Pseudomonas aeruginosa Pyocyanin Is Critical for Lung Infection in Mice , 2004, Infection and Immunity.
[20] K. Kaestner,et al. Foxa2 regulates alveolarization and goblet cell hyperplasia , 2004, Development.
[21] F. Martinez,et al. Mechanisms of pulmonary fibrosis. , 2004, Annual review of medicine.
[22] N. Blin,et al. IL-4 and IL-13 Up-Regulate Intestinal Trefoil Factor Expression: Requirement for STAT6 and De Novo Protein Synthesis , 2004 .
[23] D. Hassett,et al. Human targets of Pseudomonas aeruginosa pyocyanin , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[24] Lian-Hui Zhang,et al. Microbial diversity and prevalence of virulent pathogens in biofilms developed in a water reclamation system. , 2003, Research in microbiology.
[25] P. Ohtake,et al. Aberrant lung structure, composition, and function in a murine model of Hermansky-Pudlak syndrome. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[26] G. Denning,et al. Phenazine-1-carboxylic acid, a secondary metabolite of Pseudomonas aeruginosa, alters expression of immunomodulatory proteins by human airway epithelial cells. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[27] Jae Young Choi,et al. Interleukin-1β and Tumor Necrosis Factor-α Induce MUC5AC Overexpression through a Mechanism Involving ERK/p38 Mitogen-activated Protein Kinases-MSK1-CREB Activation in Human Airway Epithelial Cells* , 2003, Journal of Biological Chemistry.
[28] Y. Ho,et al. Stimulation of Airway Mucin Gene Expression by Interleukin (IL)-17 through IL-6 Paracrine/Autocrine Loop* , 2003, The Journal of Biological Chemistry.
[29] J. Whitsett,et al. Pneumonitis and Emphysema in sp-C Gene Targeted Mice* , 2003, The Journal of Biological Chemistry.
[30] J. Alcorn,et al. Pseudomonas aeruginosa elastase degrades surfactant proteins A and D. , 2003, American journal of respiratory cell and molecular biology.
[31] R. Boucher,et al. An overview of the pathogenesis of cystic fibrosis lung disease. , 2002, Advanced drug delivery reviews.
[32] M. Muller,et al. Pyocyanin induces oxidative stress in human endothelial cells and modulates the glutathione redox cycle. , 2002, Free radical biology & medicine.
[33] Mark J. Smyth,et al. Functional significance of the perforin/granzyme cell death pathway , 2002, Nature Reviews Immunology.
[34] S. Kunkel,et al. Airway hyperresponsiveness, but not airway remodeling, is attenuated during chronic pulmonary allergic responses to Aspergillus in CCR4‐/‐ mice , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[35] R. Vabulas,et al. Bacterial CpG‐DNA and lipopolysaccharides activate Toll‐like receptors at distinct cellular compartments , 2002, European journal of immunology.
[36] M. Borchers,et al. CD4(+) T cell-dependent airway mucus production occurs in response to IL-5 expression in lung. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[37] P. O'Byrne,et al. Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[38] Gerald B. Pier,et al. Lung Infections Associated with Cystic Fibrosis , 2002, Clinical Microbiology Reviews.
[39] G. Taylor,et al. Induction of Neutrophil Apoptosis by the Pseudomonas aeruginosa Exotoxin Pyocyanin: A Potential Mechanism of Persistent Infection1 , 2002, The Journal of Immunology.
[40] R. Puri,et al. Stat6-deficient mice develop airway hyperresponsiveness and peribronchial fibrosis during chronic fungal asthma. , 2002, The American journal of pathology.
[41] R. Homer,et al. Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1 , 2001, The Journal of experimental medicine.
[42] V. Kurup,et al. IL-13 and IFN-γ: Interactions in Lung Inflammation1 , 2001, The Journal of Immunology.
[43] J. Eyles,et al. Tissue distribution of radioactivity following intranasal administration of radioactive microspheres , 2001, The Journal of pharmacy and pharmacology.
[44] W. Foster,et al. Methodology for the measurement of mucociliary function in the mouse by scintigraphy. , 2001, Journal of applied physiology.
[45] W. Khan,et al. Stat6 dependent goblet cell hyperplasia during intestinal nematode infection , 2001, Parasite immunology.
[46] Matthew R. Parsek,et al. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms , 2000, Nature.
[47] J. Jen,et al. Interleukin-9 upregulates mucus expression in the airways. , 2000, American journal of respiratory cell and molecular biology.
[48] K. Dabbagh,et al. Oxidative Stress Causes Mucin Synthesis Via Transactivation of Epidermal Growth Factor Receptor: Role of Neutrophils1 , 2000, The Journal of Immunology.
[49] N. Letwin,et al. Model systems for investigating mucin gene expression in airway diseases. , 2000, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[50] S. Wenzel,et al. Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells. , 1999, The Journal of clinical investigation.
[51] C. D. Cox,et al. The Pseudomonas aeruginosa Secretory Product Pyocyanin Inactivates α1 Protease Inhibitor: Implications for the Pathogenesis of Cystic Fibrosis Lung Disease , 1999, Infection and Immunity.
[52] K. Kuwano,et al. The involvement of Fas-Fas ligand pathway in fibrosing lung diseases. , 1999, American journal of respiratory cell and molecular biology.
[53] C. Mackay,et al. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. , 1998, Immunology today.
[54] W. Abraham,et al. Mechanism of pyocyanin- and 1-hydroxyphenazine-induced lung neutrophilia in sheep airways. , 1998, Journal of applied physiology.
[55] L. Stoll,et al. Pseudomonas Pyocyanin Increases Interleukin-8 Expression by Human Airway Epithelial Cells , 1998, Infection and Immunity.
[56] Jian-Dong Li,et al. Activation of NF-kappaB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[57] J. Costerton,et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm. , 1998, Science.
[58] T. Sorrell,et al. Modulation of neutrophil superoxide response and intracellular diacylglyceride levels by the bacterial pigment pyocyanin , 1997, Infection and immunity.
[59] B. Stripp,et al. Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[60] C. D. Cox,et al. Pyocyanin from Pseudomonas aeruginosa inhibits prostacyclin release from endothelial cells , 1995, Infection and immunity.
[61] T. Sorrell,et al. Inhibition of Platelet Eicosanoid Metabolism by the Bacterial Phenazine Derivative Pyocyanin , 1994, Annals of the New York Academy of Sciences.
[62] W. Abraham,et al. Extracellular metabolites of Pseudomonas aeruginosa produce bronchoconstriction by different mechanisms. , 1994, American journal of respiratory and critical care medicine.
[63] C. D. Cox,et al. Interaction of the Pseudomonas aeruginosa secretory products pyocyanin and pyochelin generates hydroxyl radical and causes synergistic damage to endothelial cells. Implications for Pseudomonas-associated tissue injury. , 1992, The Journal of clinical investigation.
[64] J. Shellito,et al. Effect of pyocyanine, a pigment of Pseudomonas aeruginosa, on production of reactive nitrogen intermediates by murine alveolar macrophages , 1992, Infection and immunity.
[65] T. Sorrell,et al. Leukotriene B4 omega-oxidation by human polymorphonuclear leukocytes is inhibited by pyocyanin, a phenazine derivative produced by Pseudomonas aeruginosa , 1992, Infection and immunity.
[66] G. Taylor,et al. Effect of Pseudomonas aeruginosa-derived pyocyanin and 1-hydroxyphenazine on pulmonary mucociliary clearance monitored scintigraphically in the baboon model. , 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[67] R. Wilson,et al. Effect of pyocyanin and 1-hydroxyphenazine on in vivo tracheal mucus velocity. , 1989, Journal of applied physiology.
[68] G. Taylor,et al. Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium , 1988, Infection and immunity.
[69] D. Hyde,et al. Effect of murine gamma interferon on the cellular responses to bleomycin in mice. , 1988, Experimental lung research.
[70] D. Dearborn,et al. Studies on the mechanism of T cell inhibition by the Pseudomonas aeruginosa phenazine pigment pyocyanine. , 1987, Journal of immunology.
[71] B. Holloway,et al. Chromosomal genetics of Pseudomonas. , 1979, Microbiological reviews.
[72] Thurlbeck Wm. Measurement of pulmonary emphysema. , 1967 .
[73] W. Thurlbeck. Measurement of pulmonary emphysema. , 1967, The American review of respiratory disease.
[74] King Eo,et al. Two simple media for the demonstration of pyocyanin and fluorescin. , 1954 .
[75] E. King,et al. Two simple media for the demonstration of pyocyanin and fluorescin. , 1954, The Journal of laboratory and clinical medicine.